MPO-ANCA positive glomerulonephritis during PD-1 inhibitor combined with anti-CTLA4 antibody in lung cancer

J Chemother. 2024 Feb;36(1):82-83. doi: 10.1080/1120009X.2023.2212207. Epub 2023 May 14.

Authors

Kyoichi Kaira¹, Tomohiro Ikezawa², Tsutomu Inoue², Hisao Imai¹, Hirokazu Okada², Hiroshi Kagamu¹

Affiliations

¹ Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka City, Japan.
² Department of Nephrology, Faculty of Medicine, Saitama Medical University, Iruma-gun, Moroyama-cho, Japan.

PMID: 37183486
DOI: 10.1080/1120009X.2023.2212207

No abstract available

MeSH terms

Antibodies, Antineutrophil Cytoplasmic
Glomerulonephritis*
Humans
Immune Checkpoint Inhibitors
Lung Neoplasms*

Substances

Antibodies, Antineutrophil Cytoplasmic
Immune Checkpoint Inhibitors